SMTL ID : 6brb.1

Novel non-antibody protein scaffold targeting CD40L

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.82 Å

Oligo State

hetero-3-3-mer

Ligands

3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.1: 15 residues within 4Å: Chain A: S.17, I.71, S.73, C.75, E.83, R.84, I.85, R.88, N.121, V.122, T.123 Chain D: D.19, F.20, G.21, E.22 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.2: 15 residues within 4Å: Chain C: S.17, I.71, S.73, C.75, E.83, R.84, I.85, R.88, N.121, V.122, T.123 Chain F: D.19, F.20, G.21, E.22 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.3: 15 residues within 4Å: Chain B: D.19, F.20, G.21, E.22 Chain E: S.17, I.71, S.73, C.75, E.83, R.84, I.85, R.88, N.121, V.122, T.123 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Karnell, J.L. et al., A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity. Sci Transl Med (2019)

Release Date

2018-12-05

Peptides

CD40 ligand: ACE
Tn3-like: BDF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
A

E
A

B
D

D
D

F
D

CD40 ligand

Tn3-like